AU2001246393A1 - Immunostimulating properties of a fragment of tgf-beta - Google Patents
Immunostimulating properties of a fragment of tgf-betaInfo
- Publication number
- AU2001246393A1 AU2001246393A1 AU2001246393A AU4639301A AU2001246393A1 AU 2001246393 A1 AU2001246393 A1 AU 2001246393A1 AU 2001246393 A AU2001246393 A AU 2001246393A AU 4639301 A AU4639301 A AU 4639301A AU 2001246393 A1 AU2001246393 A1 AU 2001246393A1
- Authority
- AU
- Australia
- Prior art keywords
- tgf
- fragment
- beta
- immunostimulating properties
- immunostimulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200000540 | 2000-03-31 | ||
DKPA200000540 | 2000-03-31 | ||
US24697300P | 2000-11-13 | 2000-11-13 | |
US60246973 | 2000-11-13 | ||
PCT/DK2001/000218 WO2001072331A1 (en) | 2000-03-31 | 2001-03-30 | Immunostimulating properties of a fragment of tgf-beta |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001246393A1 true AU2001246393A1 (en) | 2001-10-08 |
Family
ID=26068804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001246393A Abandoned AU2001246393A1 (en) | 2000-03-31 | 2001-03-30 | Immunostimulating properties of a fragment of tgf-beta |
Country Status (4)
Country | Link |
---|---|
US (1) | US20020160012A1 (en) |
EP (1) | EP1292330A1 (en) |
AU (1) | AU2001246393A1 (en) |
WO (1) | WO2001072331A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10026713A1 (en) * | 2000-05-30 | 2001-12-06 | Walter Sebald | Mutein a chain of a protein from the superfamily of the growth factor TGF-beta |
ATE409495T1 (en) | 2001-04-04 | 2008-10-15 | Nordic Vaccine Technology As | POLYNUCLEOTIDE BINDING COMPLEXES THAT CONTAIN STEROLS AND SAPONINS |
AU2004224317B2 (en) * | 2003-03-21 | 2009-11-12 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Finding usable portion of sigmoid curve |
EP2562182B1 (en) * | 2007-07-27 | 2015-10-07 | Immatics Biotechnologies GmbH | Novel immunogenic epitopes for immunotherapy |
GB201908012D0 (en) * | 2019-06-05 | 2019-07-17 | Io Biotech Aps | TGF-Beta vaccine |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0169016B2 (en) * | 1984-07-16 | 2004-04-28 | Celtrix Pharmaceuticals, Inc. | Polypeptide cartilage-inducing factors found in bone |
IT1200103B (en) * | 1984-08-14 | 1989-01-05 | Sandoz Ag | N-SUBSTITUTED TETRAALKYLPYRIDIN COMPOUNDS AGENTS AS LIGHT STABILIZERS FOR POLYMERIC MATERIALS |
US5116943A (en) * | 1985-01-18 | 1992-05-26 | Cetus Corporation | Oxidation-resistant muteins of Il-2 and other protein |
US4886747A (en) * | 1985-03-22 | 1989-12-12 | Genentech, Inc. | Nucleic acid encoding TGF-β and its uses |
US4894332A (en) * | 1985-03-27 | 1990-01-16 | Biogen, Inc. | DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins |
US5194254A (en) * | 1986-05-06 | 1993-03-16 | Connaught Laboratories Limited | Enhancement of antigen immunogenicity |
US5019384A (en) * | 1986-06-30 | 1991-05-28 | Massachusetts Institute Of Technology | Immunonodulating compositions and their use |
US5554372A (en) * | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
US5976541A (en) * | 1988-01-26 | 1999-11-02 | The United States Of America As Represented By The Department Of Health And Human Services | Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope |
AU1340688A (en) * | 1987-01-30 | 1988-08-24 | Techne Corporation | Transforming growth factor-beta |
AU1539188A (en) * | 1987-05-04 | 1988-11-10 | Bristol-Myers Squibb Company | TGF-B2 and novel compositions having anti-neoplastic activity |
US6780613B1 (en) * | 1988-10-28 | 2004-08-24 | Genentech, Inc. | Growth hormone variants |
US5268455A (en) * | 1989-05-25 | 1993-12-07 | Genentech, Inc. | Process for making biologically active polypeptides based on transforming growth factor-βsequences |
US5118791A (en) * | 1989-05-25 | 1992-06-02 | Genentech, Inc. | Biologically active polypeptides based on transforming growth factor-β |
US5061786A (en) * | 1989-05-25 | 1991-10-29 | Genentech, Inc. | Biologically active polypeptides based on transforming growth factor-β |
US5837269A (en) * | 1989-09-25 | 1998-11-17 | University Of Utah Research Foundation | Vaccine compositions and method for enhancing an immune response |
GB9112553D0 (en) * | 1991-06-11 | 1991-07-31 | Wellcome Found | Fusion proteins |
US5202119A (en) * | 1991-06-28 | 1993-04-13 | Genentech, Inc. | Method of stimulating immune response |
US5904920A (en) * | 1991-10-04 | 1999-05-18 | Whitehead Institute For Biomedical Research | Regulation of systemic immune responses utilizing cytokines and antigens |
US6171584B1 (en) * | 1992-02-12 | 2001-01-09 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Method of treatment with growth/differentiation factors of the TGF-β family |
US5980899A (en) * | 1992-06-10 | 1999-11-09 | The United States Of America As Represented By The Department Of Health And Human Services | Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells |
US5420243A (en) * | 1993-01-26 | 1995-05-30 | Celtrix Pharmaceuticals, Inc. | Biologically active TGF-β2 peptides |
KR960701988A (en) * | 1993-04-20 | 1996-03-28 | 윌리엄 에스. 로빈슨 | METHODS AND MATERIALS FOR TREATMENT OF INDIVIDUALS INFECTED WITH INTRACELLULAR IN-FECTIOUS AGENTS |
US5759551A (en) * | 1993-04-27 | 1998-06-02 | United Biomedical, Inc. | Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines |
CA2164505A1 (en) * | 1993-06-07 | 1994-12-22 | Phillip W. Berman | Hiv envelope polypeptides |
US5453492A (en) * | 1993-07-28 | 1995-09-26 | La Jolla Cancer Research Foundation | 60 kDa transforming growth factor-β-binding protein and its use to detect or purify TGF-β |
US5603933A (en) * | 1993-08-31 | 1997-02-18 | Board Of Regents, The University Of Texas | CD4 peptides for binding to viral envelope proteins |
US6015686A (en) * | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
US5874085A (en) * | 1993-11-10 | 1999-02-23 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Vaccine for enhanced production of IgA antibodies |
US5961979A (en) * | 1994-03-16 | 1999-10-05 | Mount Sinai School Of Medicine Of The City University Of New York | Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
US6013268A (en) * | 1994-04-22 | 2000-01-11 | Corixa Corporation | Methods for enhancement of protective immune responses |
US5876735A (en) * | 1994-04-22 | 1999-03-02 | Corixa Corporation | Methods for enhancement of protective immune responses |
US5772995A (en) * | 1994-07-18 | 1998-06-30 | Sidney Kimmel Cancer Center | Compositions and methods for enhanced tumor cell immunity in vivo |
TW440566B (en) * | 1994-07-25 | 2001-06-16 | Novartis Ag | Novel process for the production of biologically active dimeric protein |
GB9425582D0 (en) * | 1994-12-19 | 1995-02-15 | Iaf Biochem Int | Peptides having immunomodulatory activity |
US5900238A (en) * | 1995-07-27 | 1999-05-04 | Immunex Corporation | Vaccine delivery system |
US5972655A (en) * | 1998-11-19 | 1999-10-26 | The Research Foundation Of State University Of New York | Y2H61 an IKK binding protein |
-
2001
- 2001-03-30 EP EP01919233A patent/EP1292330A1/en not_active Withdrawn
- 2001-03-30 WO PCT/DK2001/000218 patent/WO2001072331A1/en not_active Application Discontinuation
- 2001-03-30 AU AU2001246393A patent/AU2001246393A1/en not_active Abandoned
- 2001-04-02 US US09/822,873 patent/US20020160012A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001072331A1 (en) | 2001-10-04 |
EP1292330A1 (en) | 2003-03-19 |
US20020160012A1 (en) | 2002-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001292909A1 (en) | Trocar assembly | |
AU2002212655A1 (en) | Remote phytomonitoring | |
AU2001275021A1 (en) | Trocar assembly | |
AU2001278601A1 (en) | Improved cam operated devices | |
AU2002345679A1 (en) | Biodegradable sorbents | |
AU2002317568A1 (en) | Technical field | |
AU2002306482A1 (en) | Pneumatic coupling | |
AU2001281965A1 (en) | Novel 6-phenylphenanthridines | |
AU2001257038A1 (en) | Electro-desorption compressor | |
AU2001244687A1 (en) | Micro-array | |
AU2002213151A1 (en) | Mechanical transmission | |
AU2001240791A1 (en) | Sequence | |
AU2001241624A1 (en) | Stapler | |
AU2001246393A1 (en) | Immunostimulating properties of a fragment of tgf-beta | |
AU2002350314A1 (en) | Can end | |
AU2001286775A1 (en) | Adjuvant | |
AU2001254782A1 (en) | Manual actuating means | |
AU2001223878A1 (en) | Sealant | |
AU2002302604A1 (en) | Process connection | |
AU2002366300A1 (en) | A phantom | |
AU2001274750A1 (en) | Novel beta-hydroxyamides | |
AU2002240841A1 (en) | Cytostatic-glycoconjugates having specifically cleavable peptidiclinking units | |
AU2001293719A1 (en) | Thienopyrimidine | |
AU2002223458A1 (en) | Compressor | |
AU3292800A (en) | Improved stage |